ANXA1–GSK3β interaction and its involvement in NSCLC metastasis

Chunmiao Deng,Xiaohui Liu,Cuiqiong Zhang,Lu Li,Shiyuan Wen,Xuejuan Gao,Langxia Liu
DOI: https://doi.org/10.1093/abbs/gmab067
IF: 3.7
2021-05-18
Acta Biochimica et Biophysica Sinica
Abstract:Abstract Although initially discovered and extensively studied for its role in inflammation, Annexin A1 (ANXA1) has been reported to be closely related to cancer in recent years, and its role in cancer is specific to tumor types and tissues. In the present study, we identified ANXA1 as an interaction partner of glycogen synthase kinase 3 beta (GSK3β), a multi-functional serine/threonine kinase tightly associated with cell fate determination and cancer, and assessed the functional significance of GSK3β–ANXA1 interaction in the metastasis of non-small cell lung cancer (NSCLC). We confirmed the interaction between GSK3β and ANXA1 in vitro and in H1299 and A549 cells by Glutathione-S-transferase (GST) pull-down assay and co-immunoprecipitation. We found that ANXA1 negatively regulated the phosphorylation of GSK3β and inhibited the epithelial–mesenchymal transformation (EMT) process and migration and invasion of NSCLC cells. By functional rescue assay, we confirmed that ANXA1 inhibited EMT through the regulation of GSK3β activity and thereby inhibited the migration and invasion of NSCLC cells. Our study sheds light on the function of ANXA1 and GSK3β and provides new elements for the understanding of NSCLC pathogenesis.
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?